Multiple sclerosis drug FTY-720 toxicity is mediated by the heterotypic fusion of organelles in neuroendocrine cells. (2019)
Attributed to:
New non-paralytic botulinum molecules for the control of pain
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-019-55106-w
PubMed Identifier: 31804600
Publication URI: http://europepmc.org/abstract/MED/31804600
Type: Journal Article/Review
Volume: 9
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322